Stocks
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | 2.58 | 1.82 | 0.11 | -0.30 | -3.36 | 3.06 | ||
| Changes by years, y/y, % | -24% | -30% | -94% | -366% | +1 002% | |||
Arrowhead Pharmaceuticals. Debt/EBITDA
Arrowhead Pharmaceuticals. Debt/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | LTM ? | |||
| Debt/EBITDA | 3.56 | -3.36 | -1.63 | 3.06 | 5.26 | 3.06 | ||
| Changes by years, y/y, % | -10 477% | +1 002% | +197% | -42% | +48% | |||
| Changes by quarters, q/q, % | -32% | -194% | -51% | -287% | +72% | |||
